Related Experiment Video
Updated: Jun 10, 2025
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Update on the Role of β2AR and TRPV1 in Respiratory Diseases
Sara Manti1, Antonella Gambadauro1, Francesca Galletta1
1Pediatric Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Via Consolare Valeria 1, 98124 Messina, Italy.
Abstract:
Respiratory diseases (RDs) constitute a common public health problem both in industrialized and developing countries. The comprehension of the pathophysiological mechanisms underlying these conditions and the development of new therapeutic strategies are critical for improving the quality of life of affected patients. β2-adrenergic receptor (β2AR) and transient receptor potential vanilloid 1 (TRPV1) are both involved in physiological responses in the airways. β2AR is implicated in bronchodilation, mucociliary clearance, and anti-inflammatory effects, while TRPV1 is involved in the mediation of pain and cough reflexes. In RDs, such as respiratory infections, asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, the concentration and expression of these receptors can be altered, leading to significant consequences. In this review, we provided an update on the literature about the role of β2AR and TRPV1 in these conditions. We reported how the diminished or defective expression of β2AR during viral infections or prolonged therapy with β2-agonists can increase the severity of these pathologies and impact the prognosis. Conversely, the role of TRPV1 was pivotal in neuroinflammation, and its modulation could lead to innovative treatment strategies in specific patients. We indicate future perspectives and potential personalized treatments in RDs through a comprehensive analysis of the roles of these receptors in the physiological and pathological mechanisms of these pathologies.
Insights
Respiratory diseases involve altered airway receptors. Diminished beta2-adrenergic receptor (β2AR) expression worsens outcomes, while transient receptor potential vanilloid 1 (TRPV1) offers novel therapeutic targets.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Cell Biology
Background:
- Respiratory diseases (RDs) are a significant global health concern.
- Understanding pathophysiological mechanisms and developing new therapies are crucial for patient quality of life.
- Airway receptors like beta2-adrenergic receptor (β2AR) and transient receptor potential vanilloid 1 (TRPV1) play key physiological roles.
Purpose of the Study:
- To review the current literature on the roles of β2AR and TRPV1 in various respiratory diseases.
- To analyze how alterations in these receptors impact disease severity and prognosis.
- To explore potential therapeutic strategies targeting β2AR and TRPV1 for personalized treatment in RDs.
Main Methods:
- Comprehensive literature review of studies investigating β2AR and TRPV1 in respiratory conditions.
- Analysis of receptor expression and functional changes in diseases like asthma, COPD, cystic fibrosis, and respiratory infections.
- Synthesis of findings to identify therapeutic implications and future research directions.
Main Results:
- Reduced or defective β2AR expression, seen in viral infections or with β2-agonist overuse, can exacerbate RDs and worsen prognosis.
- TRPV1 plays a critical role in neuroinflammation associated with RDs.
- Modulation of TRPV1 presents opportunities for innovative treatment strategies in select patient populations.
Conclusions:
- β2AR and TRPV1 are key players in the pathophysiology of respiratory diseases.
- Targeting these receptors, particularly TRPV1, holds promise for developing novel and personalized therapeutic approaches for RDs.
- Further research into the complex roles of these receptors can guide future treatment strategies.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:26Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:23The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
01:28Antihypertensive Drugs: Types of β-Blockers
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...